Cargando…

Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis

BACKGROUND AND OBJECTIVE: Patient characteristics require consideration for optimal treatment in order to achieve clinical remission for an improved quality of life and social functioning. Prior evidence supports long-acting injectable antipsychotics (LAIs) in the relapse prevention of schizophrenia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheung, Stephane, Hamuro, Yukinobu, Mahlich, Jörg, Nakahara, Takanobu, Sruamsiri, Rosarin, Tsukazawa, Sunny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422449/ https://www.ncbi.nlm.nih.gov/pubmed/28361438 http://dx.doi.org/10.1007/s40261-017-0517-0

Ejemplares similares

Co-insurance and health care utilization in Japanese patients with rheumatoid arthritis: a discontinuity regression approach
por: Mahlich, Jörg, et al.
Publicado: (2019)

Treatment pathways of Japanese prostate cancer patients - A retrospective transition analysis with administrative data
por: Cheung, Stephane, et al.
Publicado: (2018)

Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study
por: Mahlich, Jörg, et al.
Publicado: (2017)

Biologic treatment of Japanese patients with inflammatory bowel disease
por: Mahlich, Jörg, et al.
Publicado: (2018)

Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

The underrated prevalence of depression in Japanese patients with rheumatoid arthritis - evidence from a Nationwide survey in Japan
por: Sruamsiri, Rosarin, et al.
Publicado: (2017)

Hospitalization costs and length of stay of Japanese children with respiratory syncytial virus: A structural equation modeling approach
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

Shared Decision-Making and Patient Satisfaction in Japanese Rheumatoid Arthritis Patients: A New “Preference Fit” Framework for Treatment Assessment
por: Mahlich, Jörg, et al.
Publicado: (2019)

Cultural beliefs, utility values, and health technology assessment
por: Mahlich, Jörg, et al.
Publicado: (2018)

Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
por: Mahlich, Jörg, et al.
Publicado: (2016)

Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study
por: Miyazaki, Celine, et al.
Publicado: (2020)

Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients
por: Morishige, Ryuji, et al.
Publicado: (2016)

Impact of patient characteristics and treatment procedures on hospitalization cost and length of stay in Japanese patients with influenza: A structural equation modelling approach
por: Sruamsiri, Rosarin, et al.
Publicado: (2017)

Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data
por: Kuwabara, Hiroyo, et al.
Publicado: (2015)

Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program
por: Sruamsiri, Rosarin, et al.
Publicado: (2013)

Quality of Reporting of Randomised Controlled Trials of Herbal Interventions in ASEAN Plus Six Countries: A Systematic Review
por: Pratoomsoot, Chayanin, et al.
Publicado: (2015)

Productivity and deadweight losses due to relapses of schizophrenia in Japan
por: Nakamura, Yusuke, et al.
Publicado: (2017)

The relationship between socio-demographic factors, health status, treatment type, and employment outcome in patients with inflammatory bowel disease in Japan
por: Mahlich, J, et al.
Publicado: (2017)

Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand
por: Sruamsiri, Rosarin, et al.
Publicado: (2015)

Epidemiology of sepsis in a Japanese administrative database
por: Imaeda, Taro, et al.
Publicado: (2023)

Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan
por: Mahlich, Jörg, et al.
Publicado: (2015)

Clinical Effects of Thai Herbal Compress: A Systematic Review and Meta-Analysis
por: Dhippayom, Teerapon, et al.
Publicado: (2015)

Epidemiology and costs of dengue in Thailand: A systematic literature review
por: Thisyakorn, Usa, et al.
Publicado: (2022)

Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib
por: Mahlich, Jörg, et al.
Publicado: (2017)

Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone from the Perspective of a Japanese Hospital
por: Nakamura, Yusuke, et al.
Publicado: (2019)

Effects of Centella asiatica (L.) Urb. on cognitive function and mood related outcomes: A Systematic Review and Meta-analysis
por: Puttarak, Panupong, et al.
Publicado: (2017)

Validity of diagnoses, procedures, and laboratory data in Japanese administrative data
por: Yamana, Hayato, et al.
Publicado: (2017)

Real-World Treatment Persistence with Biologic Disease-Modifying Antirheumatic Drugs Among German Patients with Psoriatic Arthritis—A Retrospective Database Study
por: Sewerin, Philipp, et al.
Publicado: (2021)

Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis
por: Sruamsiri, Rosarin, et al.
Publicado: (2016)

Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics
por: Mahlich, Jörg, et al.
Publicado: (2020)

Clinical Effects of Krachaidum (Kaempferia parviflora): A Systematic Review
por: Saokaew, Surasak, et al.
Publicado: (2016)

Intussusception among Japanese children: an epidemiologic study using an administrative database
por: Takeuchi, Masato, et al.
Publicado: (2012)

Pharmacokinetics and Safety of Brexpiprazole Following Multiple‐Dose Administration to Japanese Patients With Schizophrenia
por: Ishigooka, Jun, et al.
Publicado: (2017)

Validity of Myocardial Infarction Diagnoses in Administrative Databases: A Systematic Review
por: McCormick, Natalie, et al.
Publicado: (2014)

Hospitalization Rates and Therapy Costs of German Schizophrenia Patients Who are Initiated on Long-Acting Injectable Medication: A Mirror-Image Study
por: Mahlich, Jörg, et al.
Publicado: (2020)

Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database
por: Kane, John M., et al.
Publicado: (2023)

The Challenges of Identifying Patients With Peripheral Artery Disease Utilizing Administrative Databases
por: Gouda, Pishoy, et al.
Publicado: (2023)

Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database
por: Nagai, Junko, et al.
Publicado: (2021)

Utility of Updated Japanese Circulation Society Guidelines to Diagnose Isolated Cardiac Sarcoidosis
por: Sato, Kimi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e4f5t1hmdjbsdutitdpmhnfhuf